Lisa Beck

Ms. Beck has over 25 years of experience in both emerging biotechnology companies and large pharma/biotech. She joined Veralox in 2022 bringing expertise in business development, corporate strategy and development, portfolio management and alliance management. Prior to joining Veralox, Ms. Beck was Senior Vice President of Business Development and Portfolio Management at Brii Biosciences, Executive Director of Business Development and Alliance Management at Alexion Pharmaceuticals, and Senior Director/Director of Business Development and Portfolio Management at GlaxoSmithKline. She has assessed, negotiated and closed over 100 significant business development transactions in her career. She received a B.S. in Biology from Vanderbilt University.